Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety Profile of Molnupiravir in the Treatment of COVID-19: A Descriptive Study Based on FAERS Data
Greta Santi Laurini, Nicola Montanaro, Domenico Motola
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 34-34
Open Access | Times Cited: 14

Showing 14 citing articles:

Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan
Shohei Shinozaki, Asuka Watanabe, Masahiro Kimata, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 189-205
Open Access | Times Cited: 9
Real-World Clinical Outcomes of Molnupiravir for the Treatment of Mild to Moderate COVID-19 in Adult Patients during the Dominance of the Omicron Variant: A Meta-Analysis
Chienhsiu Huang, Tsung-Lung Lu, Lichen Lin
Antibiotics (2023) Vol. 12, Iss. 2, pp. 393-393
Open Access | Times Cited: 18
Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera
Yuan‐Qin Min, Wei Xiong, Wei Shen, et al.
Science Advances (2024) Vol. 10, Iss. 15
Open Access | Times Cited: 8
Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting
Yoshikazu Mutoh, Takumi Umemura, Takeshi Nishikawa, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 811-811
Open Access | Times Cited: 13
Anesthesia considerations for patients with COVID-19
Nesrine Abdel Rahman Elrefai, Hala Mostafa Goma, I. Elsayed, et al.
Elsevier eBooks (2025), pp. 355-370
Closed Access
Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147
Zhe Yang, Qi Zhang, Xiaoqing Wu, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2019-2019
Open Access | Times Cited: 6
Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial
Heng Zhao, Wanting Meng, Xing Lv, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Safety Profile of Paxlovid in the Treatment of COVID-19
Bing Lv, Xin Gao, Guoqiang Zeng, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 9, pp. 666-675
Closed Access | Times Cited: 1
Molnupiravir Revisited—Critical Assessment of Studies in Animal Models of COVID-19
Henrik Berg Rasmussen, Peter Riis Hansen
Viruses (2023) Vol. 15, Iss. 11, pp. 2151-2151
Open Access | Times Cited: 3
Divergences in Antiviral Therapy for Diabetic Patients with COVID-19
Andreea Fitero, Nicoleta Negruț, Carmen Delia Nistor-Cseppento, et al.
(2024)
Open Access
Divergences in Antiviral Therapy for Diabetic Patients with COVID-19
Andreea Fitero, Nicoleta Negruț, Carmen Delia Nistor-Cseppento, et al.
Pharmacophore (2024) Vol. 15, Iss. 2, pp. 79-89
Open Access
Recent developments in the therapeutics of SARS-CoV-2 infection
Priyanka Nagu, Arun Parashar, Pankaj Sharma, et al.
One Health Bulletin (2024) Vol. 4, Iss. 4, pp. 143-156
Open Access
Role of Molnupiravir in the Treatment of COVID-19
Aman Sharma, Vaishali M. Patil, Meenakshi Dahiya, et al.
Anti-Infective Agents (2023) Vol. 21, Iss. 4
Closed Access
Development and Validation of In-vitro Release Study of Molnupiravir Capsules by RP-HPLC
Shipra Singhal, Aman Sharma, Anirudh Malik, et al.
Current Pharmaceutical Analysis (2023) Vol. 19, Iss. 7, pp. 577-585
Closed Access
Page 1

Scroll to top